Lifevantage (NASDAQ:LFVN) Stock Price Passes Below Two Hundred Day Moving Average - What's Next?

Lifevantage Corporation (NASDAQ:LFVN - Get Free Report) crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $15.71 and traded as low as $11.86. Lifevantage shares last traded at $12.38, with a volume of 206,585 shares.

Lifevantage Trading Down 2.5%

The business has a fifty day moving average of $12.74 and a two-hundred day moving average of $15.64. The company has a market cap of $163.39 million, a price-to-earnings ratio of 18.83 and a beta of 0.43.

Lifevantage (NASDAQ:LFVN - Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported $0.26 EPS for the quarter, beating analysts' consensus estimates of $0.16 by $0.10. Lifevantage had a return on equity of 34.67% and a net margin of 4.12%. The business had revenue of $58.44 million during the quarter, compared to analysts' expectations of $60.99 million.

Lifevantage Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, June 13th. Investors of record on Friday, May 30th were issued a $0.045 dividend. This represents a $0.18 annualized dividend and a dividend yield of 1.39%. The ex-dividend date of this dividend was Friday, May 30th. This is a boost from Lifevantage's previous quarterly dividend of $0.04. Lifevantage's dividend payout ratio (DPR) is currently 26.09%.

Insider Activity at Lifevantage

In related news, CFO Carl Aure sold 2,746 shares of the stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $13.39, for a total value of $36,768.94. Following the completion of the transaction, the chief financial officer directly owned 133,303 shares in the company, valued at approximately $1,784,927.17. This represents a 2.02% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 20.65% of the company's stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in LFVN. Farther Finance Advisors LLC purchased a new position in Lifevantage in the second quarter worth approximately $25,000. Cubist Systematic Strategies LLC purchased a new position in shares of Lifevantage during the first quarter worth $97,000. Brown Advisory Inc. purchased a new position in shares of Lifevantage during the first quarter worth $150,000. Cannon Global Investment Management LLC purchased a new position in shares of Lifevantage during the first quarter worth $156,000. Finally, State of Wyoming purchased a new position in shares of Lifevantage during the first quarter worth $173,000. 35.32% of the stock is currently owned by hedge funds and other institutional investors.

Lifevantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.